News & Perspective

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Oct 29, 2008

Oct 29, 2008

Experts stress vigilance over emerging, unpredictable diseases

See related article posted today: "US urged to launch major campaign against emerging diseases"

– WASHINGTON, DC (CIDRAP News) – Health authorities must remain alert to new and renascent disease threats, experts warned this week at an international medical meeting.

Apr 22, 2008

Apr 22, 2008

HHS official reports on Southeast Asia issues

(CIDRAP News) – A US Department of Health and Human Services (HHS) official today shared wrap-up perspectives on HHS Secretary Mike Leavitt's recent trip to Southeast Asia, which included discussions on virus-sharing and restrictions on the US Navy laboratory in Indonesia, updates on avian influenza collaborations, and talks on import safety.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»